| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 727.21% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 06/08/2023 | 727.21% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 05/17/2023 | 727.21% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 03/29/2023 | 727.21% | HC Wainwright & Co. | $48 → $45 | Maintains | Buy |
| 04/11/2022 | 782.35% | HC Wainwright & Co. | $49 → $48 | Maintains | Buy |
| 01/11/2022 | 727.21% | Jefferies | → $45 | Initiates Coverage On | → Buy |
| 11/24/2021 | 800.74% | HC Wainwright & Co. | $47 → $49 | Maintains | Buy |
| 10/01/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 09/14/2021 | 837.5% | Ladenburg Thalmann | → $51 | Initiates Coverage On | → Buy |
| 09/08/2021 | 727.21% | Piper Sandler | → $45 | Initiates Coverage On | → Overweight |
| 08/30/2021 | 763.97% | HC Wainwright & Co. | $22 → $47 | Maintains | Buy |
What is the target price for Aadi Bioscience (AADI)?
The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $45.00 expecting AADI to rise to within 12 months (a possible 727.21% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aadi Bioscience (AADI)?
The latest analyst rating for Aadi Bioscience (NASDAQ: AADI) was provided by HC Wainwright & Co., and Aadi Bioscience reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Aadi Bioscience (AADI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aadi Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aadi Bioscience was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
Is the Analyst Rating Aadi Bioscience (AADI) correct?
While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a reiterated with a price target of $0.00 to $45.00. The current price Aadi Bioscience (AADI) is trading at is $5.44, which is within the analyst's predicted range.